Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Notes underwriting agrmnt
|
Origo Acquisition Corp (OACQ)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2018 |
8-K
| Entry into a Material Definitive Agreement, Other Events |
06/13/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
05/23/2018 |
8-K
| Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T... |
04/12/2018 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
04/05/2018 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
03/15/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
12/08/2017 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
11/16/2017 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
10/24/2017 |
8-K
| Other Events |
10/03/2017 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
09/13/2017 |
8-K
| Quarterly results |
08/28/2017 |
8-K
| Quarterly results |
07/27/2017 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"Merger Agreement, by and between Origo Acquisition Corporation, Hightimes Holding Corp., HTHC Merger Sub, Inc., and Jose Aldeanueva in the capacity as the Origo Representative",
"Form of Voting Agreement by and among Origo Acquisition Corporation, Hightimes Holding Corp., and the shareholder of Hightimes Holding Corp. party thereto",
"Form of Non-Competition and Non-Solicitation Agreement, by the shareholder of Hightimes Holding Corp. party thereto in favor of Origo Acquisition Corporation",
"Form of Lock-Up Agreement by and between Origo Acquisition Corporation and the shareholders of Hightimes Holding Corp. party thereto",
"Form of Consulting Services Agreement by and between High Times Media Corporation and Oreva Capital Corporation",
"Media Contacts:" |
|
03/13/2017 |
8-K
| Form 8-K - Current report |
02/22/2017 |
8-K
| Form 8-K - Current report |
12/23/2016 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
12/22/2016 |
8-K
| Form 8-K - Current report |
12/19/2016 |
8-K
| Form 8-K - Current report |
12/12/2016 |
8-K
| Form 8-K - Current report |
06/13/2016 |
8-K
| Form 8-K - Current report |
05/24/2016 |
8-K
| Form 8-K - Current report |
05/23/2016 |
8-K
| Form 8-K - Current report |
03/21/2016 |
8-K
| Form 8-K - Current report |
02/04/2016 |
8-K
| Form 8-K - Current report |
11/25/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
10/09/2015 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
03/23/2015 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
01/06/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
12/29/2014 |
8-K
| Asset disposition |
12/23/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
12/18/2014 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Docs:
|
"CB Pharma Acquisition Corp. Lindsay A. Rosenwald, M.D. Co-Chairman of the Board and Chief Executive Officer",
"CB Pharma Acquisition Corp. Announces Closing of Initial Public Offering BURLINGTON, MA, December 18, 2014 -- CB Pharma Acquisition Corp. , a Cayman Islands exempted company formed as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities, announces the closing of its December 12, 2014 initial public offering of 4,000,000 units at $10.00 per unit. The total gross proceeds to CB Pharma Acquisition Corp. from this offering are approximately $40 million before deducting the underwriting discount and other estimated offering expenses payable by CB Pharma. Each unit consists of one ordinary share, one right to receive one-tenth of..." |
|
|
|